Physician profile
Marc Arnkoff
NPI 1144200270
$18,226.90
in general payments reported to CMS, 2019-2025
27 companies · $71.81 in 2025
The $71.81 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,719 · 2020: $4,422 · 2021: $2,051 · 2022: $1,772 · 2023: $231 · 2024: $960 · 2025: $71.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $829 · Food and Beverage: $434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $829.00 |
| Food and Beverage | $434.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Great Lakes Medical Services, LLC | $16,853.00 | 2019-2024 | |
| Antares Pharma, INC. | $155.45 | 2022 | |
| Astellas Pharma US INC | $153.04 | 2019-2023 | Xtandi |
| Procept Biorobotics Corporation | $149.48 | 2022-2023 | Aquabeam Robotic System |
| Blue Earth Diagnostics | $147.64 | 2019-2021 | |
| Clarus Therapeutics INC. | $144.31 | 2020-2021 | |
| Srs Medical Systems, INC. | $78.67 | 2020-2023 | Urocuff |
| Abbvie INC. | $66.80 | 2023-2024 | Lupron Depot |
| Merck Sharp & Dohme LLC | $64.58 | 2022-2024 | Keytruda, Welireg, Lynparza |
| Janssen Biotech, INC. | $58.96 | 2022-2025 | Erleada |
| Astrazeneca Pharmaceuticals LP | $45.24 | 2023 | Lynparza |
| Myriad Genetic Laboratories, INC. | $27.53 | 2021-2023 | Prolaris |
| Analogic Corporation | $26.55 | 2019 | |
| Genzyme Corporation | $24.67 | 2021 | |
| Teleflex LLC | $22.47 | 2024 | Urolift |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $21.03 | 2025 | |
| Boston Scientific Corporation | $20.40 | 2024 | Rezum Generator |
| Azurity Pharmaceuticals, INC. | $20.38 | 2025 | Azmiro |
| 180 Medical, INC. | $20.29 | 2021 | |
| Ferring Pharmaceuticals INC. | $18.06 | 2024 | Adstiladrin |
| Axonics, INC. | $17.68 | 2020 | |
| Olympus America INC. | $17.40 | 2023 | Itind System |
| Angiodynamics, INC. | $17.26 | 2024 | Nanoknife |
| Allergan, INC. | $15.75 | 2021 | |
| Convatec INC. | $15.10 | 2022 | |
| Laborie Medical Technologies Corp. | $13.55 | 2023 | |
| Endo Pharmaceuticals INC. | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$65,800.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Arnkoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.